1972
DOI: 10.3181/00379727-139-36126
|View full text |Cite
|
Sign up to set email alerts
|

Enhancement and Suppression of Murine Sarcoma Virus Induced Tumors by Polyriboinosinic Polyribocytidylic Acid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
4
0

Year Published

1972
1972
1983
1983

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…In contrast, the following substances inhibit primary tumorigenesis: BCG in the MSV-mouse (Schwartz et al, 1971;Houchens et al, 1973), polyoma-hamster and -mouse (Lemonde and Clode-Hyde, 1966), and adenovirus-mouse systems; Freund's complete adjuvant in the adenovirus-mouse system ; thymosin in the MSV-mouse system (Zisblatt et al, 1970); polyribonucleotides (Sarma et al, 1969;Gazdar et al, 1972a;De Clercq and Stewart, 1974) and interferon (Berman, 1970) in the MSV-mouse system; clam liver extract in the adenovirus 12-hamster system (Li et ai., 1972); lipid-restim in the RSV-chicken system (Bliznakov, 1968); rifampicin (Toolan and Ledinko, 1972) and methotrexate (Li et ai., 1972) in the adenovirus-hamster system; cyclophosphamide in the MSV-mouse system, and estrone in the SV40-hamster system (Ohtaki, 1978). Endotoxin (Strausser and Bober, 1972) inhibited the growth of MSV mouse tumors; cyclophosphamide and retinoic acid stimulated CRA activity (Glaser, 1979c) and enhanced activity of the Winn test (Glaser, 1979d;Glaser and Lotan, 1979) in the SV40-mouse system.…”
Section: The Primary In Vivo Systemsmentioning
confidence: 99%
“…In contrast, the following substances inhibit primary tumorigenesis: BCG in the MSV-mouse (Schwartz et al, 1971;Houchens et al, 1973), polyoma-hamster and -mouse (Lemonde and Clode-Hyde, 1966), and adenovirus-mouse systems; Freund's complete adjuvant in the adenovirus-mouse system ; thymosin in the MSV-mouse system (Zisblatt et al, 1970); polyribonucleotides (Sarma et al, 1969;Gazdar et al, 1972a;De Clercq and Stewart, 1974) and interferon (Berman, 1970) in the MSV-mouse system; clam liver extract in the adenovirus 12-hamster system (Li et ai., 1972); lipid-restim in the RSV-chicken system (Bliznakov, 1968); rifampicin (Toolan and Ledinko, 1972) and methotrexate (Li et ai., 1972) in the adenovirus-hamster system; cyclophosphamide in the MSV-mouse system, and estrone in the SV40-hamster system (Ohtaki, 1978). Endotoxin (Strausser and Bober, 1972) inhibited the growth of MSV mouse tumors; cyclophosphamide and retinoic acid stimulated CRA activity (Glaser, 1979c) and enhanced activity of the Winn test (Glaser, 1979d;Glaser and Lotan, 1979) in the SV40-mouse system.…”
Section: The Primary In Vivo Systemsmentioning
confidence: 99%
“…Previous studies demonstrated that pretreatment with several interferon inducers of widely differing chemical composition and origin enhanced oncogenesis by RNA leukemia and sarcoma viruses (11). Tumor enhancement by rI*rC was not related to its adjuvant-like effects on humoral immunity, and was independent of the induced circulating interferon levels (6,10). Our present studies, demonstrating enhancement of the in vitro effects of MSV by polynucleo- tide pretreatment, provide further evidence that tumor enhancement cannot be mediated solely via in vivo operative mechanisms such as the immune system.…”
mentioning
confidence: 98%
“…Suppression of MSV oncogenesis by high doses of or continuous treatment with rI-rC may be mediated by a direct toxic or chemotherapeutic effect of the drug on the host and/or the tumor cell (10).…”
mentioning
confidence: 99%
“…Interferon inducers such as pyran copolymer, statolon, endotoxin, polyriboinosinic polyribocytidylic acid (poly [I] * poly [C ]), and Newcastle disease virus (NDV) have been shown to stimulate host resistance to viral infections (4) and nonviral infections: e.g., bacterial infections with Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae (10,23,24,25,30), and protozoal infections with Plasmodium berghei, Toxoplasma gondii, and Leishmania donovani (11,14,22,27). In some conditions, however, the interferon inducer poly(I) poly(C) enhanced the severity of viral (Moloney-sarcoma, radiation leukemia, and Friend leukemia [7,9,16,17]), bacterial (L. monocytogenes [25,26]), protozoal (Leishmania donovani and Trypanosoma cruzi [11,15,19]), and fungal (Candida albicans and C. immitis [32]) infections. The stimulatory effect of poly(I) poly(C) on these infections might reflect an increased toxicity of the double-stranded ribonucleic acid (RNA) in infected animals.…”
mentioning
confidence: 99%